Tag: Protein
“We are on the brink of transformative era in nutrition and...
In an exclusive interview, Ankit Alok Bagaria, Co- Founder, Loopworm shares insights on his company’s focus on turning insects into a powerful bioresource
Sterling Biotech to start world’s first precision fermentation-based dairy protein factory...
Spanning 27 acres, this state-of-the-art facility is expected to be operational by the first quarter of 2026
Loopworm secures prestigious EU TRACES certification for silkworm pupae-derived products, opens...
This milestone positions Loopworm, which operates a GMP+, ISO 22000, and HACCP-certified facility with a 6,000 metric tonnes per annum capacity, as a key player in the EU market for sustainable protein sources
Loopworm secures ISO 22000, GMP+ and HACCP certifications
These certificates help Loopworm establish itself as a reliable company in the supply of pet food and animal feed products in global markets
FACE TO FACE: Dr Prabuddha Kundu, Managing Director, Premas Biotech
Dr Prabuddha Kundu, Co-founder & Managing Director, Premas Biotech recently on the sidelines of Global Bio India 2024 in New Delhi shared his insights on his company focus on global collaborations, industry's key growth drivers, India's US$ 300 billion bioeconomy target by 2030 and much more.
IIT Guwahati researchers discover RNA-destroying function of the p30 Protein in...
The research team studied the biochemistry of the African Swine Fever Virus (ASFV) protein to understand infection mechanisms and develop control strategies
Plasmagen Biosciences taps into niche Indian biopharma market with launch of...
Haemocomplettan® P will cater to the 1,50,000 cardiac surgeries and over 1,800 liver transplant patients who are at risk of massive bleeding due to acquired hypofibrinogenemia
Intracellular protein delivery using hybrid nanotubes could revolutionize cancer treatment
The hybrid nanotube stamp system revolutionizes precision medicine with high efficiency and cell viability rates for cancer treatment
Fibrinolytic biomarkers for identifying patients at risk of severe COVID-19
Researchers identify associations between proteins involved in fibrinolysis and the development of acute respiratory distress syndrome
New genetic therapy could be a gamechanger for Motor Neurone Disease...
The new treatment, dubbed CTx1000, targets pathological build-ups of the protein TDP-43 in cells in the brain and spinal cord